Kristen Beck, MD

TitlePsoriasis Fellow
InstitutionUniversity of California San Francisco
Address515 Spruce Street
San Francisco CA 94118
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Yang EJ, Beck K, Liao W. Tildrakizumab-asmn: What's in a Name? Am J Clin Dermatol. 2018 Apr 23. PMID: 29687361.
      View in: PubMed
    2. Yang EJ, Beck K, Sekhon S, Bhutani T. Pharmacy Costs of Specialty Medications for Plaque Psoriasis in the United States. J Am Acad Dermatol. 2018 Apr 16. PMID: 29673778.
      View in: PubMed
    3. Yang EJ, Sanchez IM, Beck K, Sekhon S, Wu JJ, Bhutani T. Guselkumab for the treatment of moderate-to-severe plaque psoriasis. Expert Rev Clin Pharmacol. 2018 Apr; 11(4):333-344. PMID: 29478344.
      View in: PubMed
    4. Yang EJ, Sekhon S, Beck K, Bhutani T, Koo J. Neuromodulation in Inflammatory Skin Disease. Dermatol Ther (Heidelb). 2018 Mar; 8(1):1-4. PMID: 29427206.
      View in: PubMed
    5. Dainichi T, Hayden MS, Park SG, Oh H, Seeley JJ, Grinberg-Bleyer Y, Beck K, Miyachi Y, Kabashima K, Hashimoto T, Ghosh S. PDK1 Is a Regulator of Epidermal Differentiation that Activates and Organizes Asymmetric Cell Division. Cell Rep. 2016 05 24; 15(8):1615-23. PMID: 27184845; PMCID: PMC4909264.
    6. Beck K, Dong J, Geskin LJ, Beltrani VP, Phelps RG, Carvajal RD, Schwartz G, Saenger YM, Gartrell RD. Disease stabilization with pembrolizumab for metastatic acral melanoma in the setting of autoimmune bullous pemphigoid. J Immunother Cancer. 2016; 4:20. PMID: 27096097; PMCID: PMC4835882.
    Kristen's Networks
    Derived automatically from this person's publications.
    People in Profiles who have published with this person.